Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. announced an extension of the period to consummate its initial business combination from May 6, 2026 to June 6, 2026. To fund the one‑month extension, $34,330.96 was deposited into the Company’s trust account for its public shareholders on May 6, 2026. The Company also issued an unsecured, non‑interest bearing promissory note dated May 6, 2026 in the principal amount of $34,330.96 to Aimei Health Ltd (the Sponsor) and United Hydrogen Group Inc.

Key Details

• Extension: one‑month extension of the termination date to June 6, 2026 (the eighteenth extension permitted under the Company’s Amended and Restated Articles).
• Extension payment: $34,330.96 deposited into the trust account (the lesser of $80,000 for all outstanding public shares and $0.033 per outstanding public share for the month).
• Promissory Note: $34,330.96 issued on May 6, 2026, split equally between Aimei Health Ltd and United Hydrogen Group Inc. ($17,165.48 each); unsecured and non‑interest bearing; principal due upon consummation of the business combination with United Hydrogen.
• Conversion right: the Payees may convert the note, in whole or in part, into private units at $10.00 per unit (each unit = one ordinary share plus a right to receive 1/5 of one ordinary share) by giving notice at least two business days before closing.

Why It Matters
The filing shows the company has secured funding to delay its deadline for completing a business combination for another month. The promissory note creates a new financial obligation that is repayable on closing and includes a conversion option that could result in issuance of private units (potential dilution) if exercised. Investors should note the extension count (eighteenth) and that the note is unsecured and non‑interest bearing — facts that affect the company’s capital structure and potential outcomes at closing.